Characterization of Small Molecule Profiles in the Healthy Human Gastrointestinal Tract

Gastrointestinal Symptoms in Healthy Subjects and Patients With Irritable Bowel Syndrome

NCT01457378 ·Status: COMPLETED

Confocal Laser Endomicroscopy in IBS Patients

NCT02313207 ·Status: WITHDRAWN ·Phase: NA

Effect of FODMAPs on Mucosal Inflammation in IBS Patients

NCT03221790 ·Status: UNKNOWN ·Phase: NA

Alcat Based Elimination Diet for the Treatment of Irritable Bowel Syndrome; a Randomized Double Blind Sham Control Trial

NCT05616429 ·Status: COMPLETED ·Phase: NA

Characterization of the Gut Microbiota Composition and Activity After Three Weeks of Chitin-glucan Supplementation

NCT03505177 ·Status: COMPLETED ·Phase: NA

Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)

NCT05178017 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide

NCT00584298 ·Status: COMPLETED ·Phase: PHASE1

Modified antioxIdants Bacteria for Gut Inflammation

NCT06189599 ·Status: ENROLLING_BY_INVITATION

The Effect of Micronutrient Supplementation on Gut Microbiome Composition and Function

NCT05371704 ·Status: UNKNOWN ·Phase: NA

Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome

NCT02249169 ·Status: COMPLETED

Confocal Laser Endomicroscopy to Determine Influence of Food Antigens on Mucosal Integrity

NCT05056610 ·Status: COMPLETED ·Phase: NA

Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre

NCT05058131 ·Status: UNKNOWN ·Phase: NA

Gut Microbiota in Chronic GI Diseases

NCT06532110 ·Status: RECRUITING

Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome

NCT01028898 ·Status: UNKNOWN

Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome

NCT04655599 ·Status: TERMINATED ·Phase: PHASE1

Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome

NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4

In Vivo Effects of Amylase Trypsin Inhibitors

NCT05157867 ·Status: UNKNOWN ·Phase: NA

Genetic Carbohydrate Maldigestion as a Model to Study Food Hypersensitivity

NCT05795049 ·Status: ACTIVE_NOT_RECRUITING

Characterizing Protein Biomarkers of Post-infection Irritable Bowel Syndrome

NCT06032117 ·Status: COMPLETED

Effects of Blueberries on Symptoms and Underlying Mechanisms of Functional Gastrointestinal Disorders

NCT04824976 ·Status: UNKNOWN ·Phase: NA

Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)

NCT01787253 ·Status: COMPLETED

Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance?

NCT01705171 ·Status: COMPLETED

Development of Non-invasive Methods to Study Gut Microbiome - Nutrition - Host Interactions

NCT05949411 ·Status: UNKNOWN ·Phase: NA

Cerebral Cortical Influences on Autonomic Function

NCT03869372 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway

NCT05721742 ·Status: RECRUITING ·Phase: NA